InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,129.60
(
-0.24%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.28
(
-0.23%
)
Bitcoin
60,990.89
(
0.29%
)
Post# of 252389
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Titan V

Send PM Follow Ignore
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Titan V

Re: None

Friday, 03/02/2018 7:26:53 PM

Friday, March 02, 2018 7:26:53 PM

Post# of 252389
Gene therapy biotech Homology Medicines files for a $100 million IPO
https://www.renaissancecapital.com/IPO-Center/News/55322/Gene-therapy-biotech-Homology-Medicines-files-for-a-$100-million-IPO

Homology Medicines, a preclinical biotech developing a gene therapy delivery platform for rare diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering.

The Bedford, MA-based company was founded in 2015 and plans to list on the Nasdaq under the symbol FIXX. Homology Medicines filed confidentially on December 22, 2017. BofA Merrill Lynch, Cowen & Company and Evercore ISI are the joint bookrunners on the deal. No pricing terms were disclosed.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up